MultiPlan (MPLN) delivered earnings and revenue surprises of -120.60% and 1.94%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?
Charles River Laboratories (CRL) came out with quarterly earnings of $2.66 per share, beating the Zacks Consensus Estimate of $2.50 per share. This compares to earnings of $2.46 per share a year ago.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results